身体性能较低的电池与老年人的跌倒和伤害性跌倒无关:SCOPE项目的纵向数据
Ellen Freiberger1, Paolo Fabbietti2, Andrea Corsonello3,4
1Department of Internal Medicine-Geriatrics, Institute for Biomedicine of Aging (IBA), Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
European geriatric medicine
|February 28, 2024
概括
短物理性能电池 (SPPB) 没有显著预测老年人的整体跌倒风险或伤害性跌倒. 然而,较低的SPPB得分与在家中发生跌倒的风险增加有关.
科学领域:
- 老年学是指老年学的学科.
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 跌倒和跌倒相关的伤害对老龄化人口构成重大公共卫生挑战.
- 评估跌倒风险对于在老年人中实施有效的预防战略至关重要.
研究的目的:
- 评估SCOPE项目队列中短物理性能电池 (SPPB) 对落和伤害性落的预测能力.
- 使用SPPB. 调查室内和室外落之间的潜在差异.
主要方法:
- 一项SCOPE项目的子研究包括没有基线跌倒的参与者,并对跌倒的12个月和24个月后续数据进行了跟踪.
- 通过自我报告和医学检查收集了参与者的特征,跌倒,受伤的跌倒和跌倒情况.
- 使用后勤回归模型分析了SPPB得分与随时间推移的跌倒事件之间的关联.
主要成果:
- 虽然原始分析显示SPPB得分显著区分了失败者和非失败者,但经过对共变量进行调整后,这种关联减弱了.
- 该SPPB没有显著地区分造成伤害和非造成伤害的落 (p=0.48).
- 较低的SPPB得分与24个月后在家中发生跌倒的可能性增加显著相关 (p<0.01).
结论:
- 短物理性能电池 (SPPB) 显示出预测跌倒或遭受伤害跌倒的整体风险的能力有限.
- 在家庭环境中,SPPB可能有助于识别较高风险的个人.
- 可能需要进一步的研究来完善老年人落风险评估工具.
相关概念视频
01:19The Effect of Aging on Tissues
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...